Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
BCL Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
pelcitoclax
(APG-1252) / Ascentage Pharma
NanoPac
(paclitaxel nanoformulation) / NanOlogy
seliciclib
(CYC202) / Cyclacel, Cedars-Sinai
TQB3909
/ Sino Biopharm
MIK665
/ Novartis, HitGen
AZD0466
/ AstraZeneca
ZN-d5
/ Zentalis Pharma
rosomidnar liposomal
(PNT2258) / GSK
FCN-338
/ Fosun Pharma
foselutoclax
(UBX1325) / Unity Biotech
liposome encapsulated paclitaxel
(LEP-ETU) / Insys Therap
paclitaxel submicron particle
(SOR007) / DFB Pharma, NanOlogy
OTQ923
/ Novartis, Intellia Therap
S65487
/ HitGen, Novartis, Servier
alirinetide
(GM604) / Genervon
nanoencapsulated paclitaxel
(FID-007) / ANP Technologies, Fulgent Genetics
ABT-737
/ AbbVie
AZD5991
/ AstraZeneca
BIVV003
/ Sangamo Therap, Sanofi
SPC2996
/ Roche
ST400
/ Sangamo Therap, Sanofi
HIX763
/ Novartis
Kanglaite gelcap
(KLTc) / Zhejiang Kanglaite Pharma
Lipax
(proliposomal intravesical paclitaxel) / TesoRx
TGRX-814
/ Shenzhen TargetRx
